4.8 • 1.4K Ratings
🗓️ 18 November 2021
⏱️ 18 minutes
🧾️ Download transcript
Click on a timestamp to play from that location
0:00.0 | behind the knife, the surgery podcast, |
0:03.2 | where we take a behind-the-scenes intimate look |
0:05.4 | at surgery from leaders in the field. |
0:07.6 | Hi, everybody, and so great to have another session of the ACE ECTS meeting. |
0:26.2 | I'm going to talk a little bit about how to deal with a clinically staged T2-N0 mid-rectal |
0:31.0 | cancer lesion. |
0:32.0 | And these lesions are sometimes tough. |
0:33.3 | I don't have any disclosures. |
0:35.4 | So in order to think about any rectal cancer, I like to think about |
0:37.5 | this kind of paradigm. |
0:39.5 | On one hand, we want to make sure that we have optimal cure rate, but we're also thinking |
0:42.6 | about morbidity, function, and overall mortality. |
0:46.8 | And so when you look at the results of rectal cancer, it's really important to kind of consider |
0:50.6 | all of these different metrics and endpoints on the left hand side of the screen. |
0:55.4 | It's a function like, you know, are they going to wind up with a permanent stoma? |
0:59.6 | Are we going to talk about local recurrence? |
1:01.2 | And then what is everything that is in our tool bag in order to address these lesions? |
1:07.8 | So the question is, do we have a neo-adjuvant radiation therapy or do we resect? |
1:12.1 | You have to first ask yourself, what type of resection are we talking about? |
1:15.0 | Is it local? |
1:16.4 | Excision? |
1:17.4 | Is it a tannis? |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Behind The Knife: The Surgery Podcast, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Behind The Knife: The Surgery Podcast and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.